Investor Relations

SEC Filings

  o View CEL-SCI's SEC Filings  
       
  o View CEL-SCI's Section 16 Filings  

Stock Quotes

  o NYSE AMEX  

Corporate Presentation

  o View CEL-SCI Presentation  

Press Releases

  o Press Releases  
  AUGUST 16, 2010
04:11 PM NEW STORY CEL-SCI Corporation Reports Third Quarter 2010 Financial Results
  AUGUST 4, 2010
09:45 AM NEW STORY CEL-SCI Successfully Produces and Fills Multikine in New Manufacturing Facility
  JUNE 28, 2010
09:00 AM NEW STORY CEL-SCI Collaborator Presents Data Showing LEAPS Vaccine Technology Generates Dendritic Cells that can Protect Animals Against Viral Illness and Other Diseases
  MAY 27, 2010
09:15 AM CEL-SCI Announces Presentation by its Chief Scientific Officer at "Targeted Cancer Thereapies" Conference in London Today


Read the latest Letter to Shareholders 

  o Letter to Shareholders  

Read the latest Research Report on CEL-SCI

  o Research Report  

Investor Relations Contact

   

Gavin de Windt
Phone: +1 703-506-9460
E-mail: gdewindt@cel-sci.com

 

 

Research &
Clinical Trials

 

  

SEC Filings